Dasmarinas City, Philippines Clinical Trials

A listing of Dasmarinas City, Philippines clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 15 clinical trials
Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (explores what the body does to the drug), and anti-mycobacterial activity of bedaquiline (TMC207) in children and adolescents (0 months to less than [<] 18 years of age) diagnosed with confirmed or probable pulmonary multidrug resistant tuberculosis (MDR-TB), …

chest x-ray
tmc207
pulmonary tuberculosis
extensively drug-resistant tuberculosis
bedaquiline
Lung Center Of The Philippines
 (26.6 away) Contact site
  • 94 views
  • 23 Apr, 2021
  • +8 other locations
Efficacy Study With QIVc in Pediatric Subjects

This phase 3 clinical study is a randomized, observer-blind, multicenter study of QIVc versus a non-influenza vaccine in subjects 6 months though 47 months of age. The purpose of this study is to evaluate efficacy of QIVc in the prevention of Reverse transcription polymerase chain reaction (RT-PCR) confirmed influenza A …

strain
PCR test
trivalent influenza vaccine
vaccination
807 Asian Hospital and Medical Center
 (9.8 away) Contact site
  • 70 views
  • 19 Mar, 2021
  • +61 other locations
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients

The purpose of this study is to compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing confirmed or probable active tuberculosis (TB) during 96 weeks of follow-up among high-risk household contacts (HHCs) of adults with multidrug-resistant tuberculosis (MDR-TB) (index cases). …

absolute neutrophil count
hhcs
antibody test
rifampin
delamanid
De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC)
 (2.2 away) Contact site
  • 137 views
  • 04 Apr, 2021
  • +26 other locations
A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient

This is an open-label, randomised, multicenter, Mircera-controlled, parallel-group, Phase III study to determine whether subcutaneous administered efepoetin alfa is as effective and well tolerated as subcutaneous Mircera for anaemia correction and maintenance in erythropoiesis stimulating agent (ESA)-nave subjects who have CKD and are not on dialysis. ESA prior users who …

National Kidney and Transplant Institute
 (79.2 away) Contact site
  • 251 views
  • 26 Jan, 2021
  • +39 other locations
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults

This Phase 2, randomized, observer-blind, antigen and adjuvant dose-ranging Clinical study is evaluating different formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine. Approximately 800 subjects are to be randomized into 1 of 8 possible treatment groups. Immunogenicity and safety will be assessed in the overall study population (adults 50 years …

strain
quadrivalent inactivated influenza vaccine
vaccination
immunomodulators
trivalent influenza vaccine
60805 - Manila Doctors' Hospital
 (19.5 away) Contact site
  • 0 views
  • 03 Jun, 2021
  • +34 other locations
A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

The purpose of the study is to evaluate the efficacy of rilematovir compared to placebo treatment with respect to the clinical outcome on the RSV Recovery Scale (RRS).

Philippine General Hospital
 (18.9 away) Contact site
  • 0 views
  • 16 May, 2021
  • +205 other locations
Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes Dyslipidemia and Hypertension

The phase III trial is designed with an aim of determining the efficacy of Investigational Product TRC150094 in concurrently reducing non-traditional risk factors for CV risk i.e., HbA1c, MAP and non-HDL cholesterol. This study will be a randomized, double blind, parallel group, placebo controlled, multi-centre, multinational study in 1250 subjects. …

hdl cholesterol
cholesterol level
oral hypoglycemic
dyslipidemia
hemoglobin a1c
Angeles University Foundation Medical Center
 (63.2 away) Contact site
  • 454 views
  • 24 Jan, 2021
  • +24 other locations
A Study to Determine the Efficacy Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) Versus Meropenem (MER) Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

A Phase 3 comparative study to determine the efficacy, safety and tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) versus Meropenem (MER) Colistin (COL) for the treatment of serious infections due to Gram negative bacteria.

antibiotic therapy
chest x-ray
ct scan
antibiotics
metronidazole
Philippine General Hospital, Central Intensive Care Unit
 (20.8 away) Contact site
  • 185 views
  • 30 May, 2021
  • +181 other locations
A Trial to Compare the Efficacy Safety Pharmacokinetics and Immunogenecity of HD204 to Avastin in Advanced Non-squamous Non-small Cell Lung Cancer Patients

In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin. The aim of the study is to demonstrate equivalence of HD204 and EU-licensed Avastin in terms of efficacy, safety, pharmacokinetics and immunogenecity.

measurable disease
lung cancer
paclitaxel
non-squamous non-small cell lung cancer
carboplatin
Asian Hospital and Medical Center
 (9.3 away) Contact site
  • 80 views
  • 30 Apr, 2021
  • +22 other locations
Study to Demonstrate the Efficacy Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

The purpose of this global study is to demonstrate the efficacy, safety, and tolerability of an intravenous (i.v.) regimen of secukinumab compared to placebo in subjects with active axSpA at Week 16 despite current or previous NSAID, DMARD and/or anti Tumor Necrosis Factor (TNF) therapy. In addition, to further support …

Novartis Investigative Site
 (20.8 away) Contact site
  • 51 views
  • 09 Jun, 2021
  • +106 other locations